Several reasons explained the variation in the results of 22 meta-analyses addressing the same question

被引:11
作者
Khamis, Assem M. [1 ]
El Moheb, Mohamad [2 ]
Nicolas, Johny [2 ]
Iskandarani, Ghida [2 ]
Refaat, Marwan M. [3 ]
Akl, Elie A. [1 ,3 ,4 ]
机构
[1] Amer Univ Beirut, Med Ctr, Clin Res Inst, Beirut, Lebanon
[2] Amer Univ Beirut, Med Ctr, Fac Med, Beirut, Lebanon
[3] Amer Univ Beirut, Med Ctr, Dept Internal Med, POB 11-0236 Riad El Solh, Beirut 11072020, Lebanon
[4] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
关键词
Statistics methods; Systematic review; Meta-analysis; Time-to-event; Meta-research; Quality of research; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; NONISCHEMIC CARDIOMYOPATHY; PRIMARY PREVENTION; DILATED CARDIOMYOPATHY; MORTALITY; INTERVENTIONS; AMIODARONE; DATABASE; REVIEWS; TRIAL;
D O I
10.1016/j.jclinepi.2019.05.023
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
100404 [儿少卫生与妇幼保健学];
摘要
Objective: The objective of this study was to assess and to investigate the reasons for the variations between the results of meta analyses addressing the same question. Study Design and Setting: We included systematic reviews, and the trials that they included, on the use of implantable cardiac defibrillator (ICD) in patients with nonischemic cardiomyopathy. We assessed the variation between meta-analyses pooled effect estimates by calculating the percentage of absolute difference. We developed a list of 10 reasons for variations between the results of the meta-analyses clustered in four overarching categories. Results: We identified 21 systematic reviews including six trials and reporting on 22 eligible meta-analyses. The percentage of absolute difference between each of the 22 pooled effect estimates (included odds ratio, risk ratio, hazard ratio) and their median value had an average of 3.2%, The number of trials for which the following categories of reasons for variations applied were as follows: (1) different decision to include or exclude trials (n = 3); (2) differences in analytical approaches (n = 6); (3) errors in conducting meta-analyses (n = 5); and (4) unclear reason (n = 1). Conclusion: Few of the observed variations between the results of the 22 meta-analyses could lead clinicians or guideline development organizations to adopt different courses of actions. Variations were most frequently related to both errors and variations in trial eligibility and analytical approaches. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:147 / 158
页数:12
相关论文
共 52 条
[1]
Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis [J].
Akel, Tamer ;
Lafferty, James .
CARDIOVASCULAR THERAPEUTICS, 2017, 35 (03)
[2]
ROLE OF IMPLANTABLE DEFIBRILLATORS IN PRIMARY PREVENTION OF MORTALITY IN NON-ISCHEMIC CARDIOMYOPATHY PATIENTS [J].
Akinapelli, Abhilash ;
Patel, Aashay ;
Saadi, Abdulghani ;
Azzouz, Muhammad Soubhi ;
Kanmanthareddy, Arun ;
Saurav, Alok ;
Aboeata, Ahmed .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) :385-385
[3]
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age? [J].
Al-Khatib, Sana M. ;
Pokorney, Sean D. .
CIRCULATION, 2017, 136 (19) :1781-1783
[4]
Implantable cardiac defibrillator and mortality in non-ischaemic cardiomyopathy: an updated meta-analysis [J].
Alba, Ana C. ;
Foroutan, Farid ;
Posada, Juan Duero ;
Battioni, Luciano ;
Schofield, Toni ;
Alhussein, Mosaad ;
Agoritsas, Thomas ;
Spencer, Frederick A. ;
Guyatt, Gordon .
HEART, 2018, 104 (03) :230-236
[5]
Calculating the number needed to treat for trials where the outcome is time to an event [J].
Altman, DG ;
Andersen, PK .
BRITISH MEDICAL JOURNAL, 1999, 319 (7223) :1492-1495
[6]
[Anonymous], EFFICACY IMPLANTABLE
[7]
[Anonymous], AM J MED
[8]
Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy -: The cardiomyopathy trial (CAT) [J].
Bänsch, D ;
Antz, M ;
Boczor, S ;
Volkmer, M ;
Tebbenjohanns, J ;
Seidl, K ;
Block, M ;
Gietzen, F ;
Berger, J ;
Kuck, KH .
CIRCULATION, 2002, 105 (12) :1453-1458
[9]
Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials [J].
Barakat, Amr F. ;
Saad, Marwan ;
Elgendy, Akram Y. ;
Mentias, Amgad ;
Abuzaid, Ahmed ;
Mahmoud, Ahmed N. ;
Elgendy, Islam Y. .
BMJ OPEN, 2017, 7 (06)
[10]
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237